Quantification of CMV DNA during NIPS is accurate and sensitive for CMV viral load; stratifies risk for primary maternal infection, cCMV.

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...

Explore the benefits of prenatal DNA screening to detect cytomegalovirus in early pregnancy for better health decisions.

Myriad Genetics, Inc. has announced the early access launch of its FirstGeneTM Multiple Prenatal Screen, which provides a comprehensive prenatal genetic risk assessment through a single blood draw, ...

Genedx Holding Corp. launched Genomedx Prenatal, its whole genome sequencing test, to provide more definitive diagnoses of the causes of fetal abnormalities identified by ultrasound. By combining the ...